Nano-based Dressing, From The Challenge Of Innovation And Technology To Product Commercialization

the startup company panotech, which was recognized in the innovation and technology challenges of "diabetic foot wound dressings", has succeeded in producing dressings that help treat diabetic wounds and high burns. this product has received nanoscale license and is being commercialized. one of the nano startups has succeeded in producing a dressing for the treatment of diabetic wounds and burns with high efficiency. panotech was recognized for the first time in the innovation and technology challenges of the special task force for the development of nanotechnology, and during the technological challenge of "diabetic foot wound dressings", the startup panotech was able to be among the top startups in this program. during the nanofiber-based wound dressings technology fair held during the second international nanofiber conference at tehran university of medical sciences, the shazan accelerator became interested in investing in this startup, and since january 2017, panotech nano zist polymer group has continued its activities with the investment of this accelerator.

panotech has succeeded in producing a dressing with microbial cellulose nanofibers. a dressing that is used to treat diabetic wounds and burns. this dressing, by using nanotechnology, improves the efficiency of wound healing compared to other dressings. this product is also less expensive than foreign dressings. another advantage of this product compared to similar foreign samples is its production speed and repeatability, which makes its industrial production more efficient. using this dressing reduces the duration of the disease treatment period, which also reduces treatment costs. in addition, due to its transparent structure, the doctor can examine the condition of the wound and manage the treatment process better. also, due to its nanostructure, this dressing can be placed on the wound for a longer period of time and, while allowing oxygen to pass to the wound surface, prevent microorganisms from entering the wound surface.

the dressing material is also cellulose, which is produced from bacterial synthesis. this product has currently received nanoscale approval and has successfully passed animal tests, and will soon enter the market after receiving approval from the food and drug administration.